MEDVi Semaglutide Cost vs PlexusDx (2026): What You'll Actually Pay

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Full head-to-head: PlexusDx vs MEDVi →

If you’re pricing MEDVi semaglutide against PlexusDx, the headline number depends on which page you land on. MEDVi’s ongoing compounded semaglutide injection rate is $299/month, and prepaid plans are charged as one total up front. MEDVi also offers a dissolvable GLP-1 tablet whose price is shown after the intake questionnaire (verified July 2026). PlexusDx prices its compounded GLP-1 protocols on one canonical page: Semaglutide Injection at $189/mo, Semaglutide Oral $289/mo month-to-month, or from $249/mo on the 6-month plan, Microdose GLP-1 Protocol at $129/mo flat, and GLP-Squared at $289/mo — all cash-pay, no membership, all 50 states (five require a live consult). This article walks the published MEDVi semaglutide pricing as of April 2026 and the side-by-side cost math against PlexusDx, so you can decide whether MEDVi’s intro hook actually wins on annualized cost.

MEDVi semaglutide pricing at a glance (April 2026)

MEDVi lists compounded semaglutide injection at $299/month ongoing. Multi-month prepaid plans are also offered. MEDVi also offers a dissolvable GLP-1 tablet taken once daily; its price is shown after the intake questionnaire (verified July 2026), so no specific tablet figure is published here. MEDVi’s brand-name Wegovy routes use a separate membership-plus-medication structure that isn’t bundled into the compounded pricing above. PlexusDx Semaglutide Injection sits at $189/mo across five dose levels (0.25mg to 2.0mg weekly), and Semaglutide Oral is $289/mo month-to-month across six dose levels (3mg to 24mg daily) — flat protocol pricing, no intro hook, no membership.

The annualized cost reconciliation: MEDVi vs PlexusDx

For a cash-pay patient with no insurance coverage for weight-loss drugs, here’s the math that actually matters. MEDVi standard path: $299/month × 12 months = $3,588/year. Prepaid multi-month options are available as well, though the rate MEDVi publishes on an ongoing basis for semaglutide is $299/month. MEDVi’s dissolvable tablet is priced after the intake questionnaire, so its annual cost isn’t published here. By comparison, PlexusDx Microdose GLP-1 Protocol at $129/mo flat totals $1,548/year. Semaglutide Injection at $189/mo totals $2,268/year. Semaglutide Oral at $289/mo totals $3,468/year. GLP-Squared at $289/mo totals $3,468/year. PlexusDx Semaglutide Injection comes in roughly $1,180 below MEDVi’s standard path, and the Microdose GLP-1 Protocol is roughly $1,900 below MEDVi’s standard path on a 12-month basis — without intro-pricing math or commitment plans.

How MEDVi structures semaglutide pricing

MEDVi’s semaglutide pricing centers on a standing ongoing rate of $299/month, which applies to compounded semaglutide injection. The number you see first depends on whether a page leads with the promo, the ongoing rate, or a prepay offer, so confirm which one applies to your specific plan at checkout. PlexusDx publishes all six Weight Management Protocol prices on individual product pages and keeps them stable: Semaglutide Injection $189/mo, Semaglutide Oral $289/mo month-to-month, or from $249/mo on the 6-month plan, Microdose GLP-1 Protocol $129/mo, Tirzepatide Injection $289/mo, Tirzepatide Oral $349/mo, and GLP-Squared $289/mo. The number on the product page is the number you’ll be charged.

Does the price go up at higher doses?

This is a question MEDVi answers explicitly: per its public pages, compounded semaglutide injection refills are described as “locked” at $299/month regardless of where you sit on the dose ladder. Patient reviews on third-party platforms generally corroborate that the refill rate stays flat as titration moves from 0.25mg up through 2.0mg weekly. If dose-locked pricing is decisive for your decision, confirm in writing with MEDVi support before paying — a flat refill on standard plans does not necessarily mean a flat refill on every partner plan you might be enrolled in. PlexusDx Semaglutide Injection is $189/mo across all five dose levels — the price is published on the product page rather than disclosed at refill time. Wherever you land on the titration ladder, your monthly stays $189 — still below MEDVi’s flat $299 refill.

Injection vs oral: the cost gap MEDVi doesn’t fully publish

MEDVi’s compounded semaglutide tablet is a daily dissolvable whose price is shown after the intake questionnaire (verified July 2026) rather than published up front — so you’d confirm the exact figure at checkout when budgeting a 12-month protocol. PlexusDx Semaglutide Oral publishes pricing $289/mo month-to-month, or from $249/mo on the 6-month plan across six dose levels (3mg, 7mg, 14mg, 17mg, 21mg, and 24mg daily). If a daily oral GLP-1 fits your needle aversion or schedule better than a weekly injection, the oral path is the same compounded active ingredient delivered as a daily tablet. Compounded oral semaglutide is not the same as Rybelsus — Rybelsus is the FDA-approved branded oral semaglutide; compounded versions are pharmacy-prepared. We’re explicit about that distinction throughout PlexusDx materials.

What’s included in the price — and what isn’t

MEDVi’s all-inclusive pricing covers the clinician evaluation, compounded medication, supplies (syringes for injection routes), and shipping under one bill — no separate membership fee on the standard compounded paths. Brand-name Wegovy routes through MEDVi use a different “membership + medication cost” model that isn’t bundled. PlexusDx pricing on every Weight Management Protocol is similarly all-inclusive: async provider consultation (or live consult in the five states that require it), prescription, compounded medication, and shipping — all in one number. There is no membership fee on any PlexusDx protocol. There’s also no insurance billing on either platform — both are cash-pay. HSA/FSA dollars generally apply to prescription GLP-1 medications under IRS rules when prescribed by a licensed clinician; using pre-tax dollars effectively reduces the out-of-pocket cost by roughly 22–35% depending on your tax bracket on either platform.

Compounded semaglutide is not FDA-approved — on either platform

This applies equally to MEDVi and to PlexusDx and is worth stating plainly. Compounded semaglutide is prepared by licensed U.S. compounding pharmacies, which are FDA-regulated entities, but the compounded formulations themselves are not FDA-approved finished drug products. Wegovy, Ozempic, and Rybelsus are the FDA-approved finished products containing semaglutide; only those branded products carry FDA approval. MEDVi’s core compounded paths and PlexusDx’s Semaglutide Injection and Semaglutide Oral protocols dispense compounded versions through licensed compounding pharmacies. The boxed warning for thyroid C-cell tumors applies to semaglutide based on rodent studies and applies whether the medication is the FDA-approved branded product or a compounded version. Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 should not use semaglutide — on any platform.

The genetic baseline MEDVi doesn’t offer

One difference between MEDVi’s pricing model and PlexusDx’s isn’t about dollars — it’s about what informs your dose. GLP-1 response varies meaningfully across patients. Variants in FTO, MC4R, TCF7L2, and the GIPR rs1800437 marker are associated with different titration responses to semaglutide. The PlexusDx Precision Peptide Genetic Test maps 49 genes and 58 variants across 14 health pathways, including 34 weight-management insights, so the prescribing clinician knows whether a faster-than-typical or slower-than-typical titration is more likely to fit your biology before week one. The test is a one-time $298 charge, separate from the monthly medication cost. MEDVi does not offer a comparable genetic stratification step.

Frequently Asked Questions

How much does MEDVi semaglutide cost per month?

MEDVi’s ongoing compounded semaglutide injection rate is $299/month. Prepaid plans are offered as well, though the published ongoing rate for semaglutide is $299/month. MEDVi’s dissolvable tablet is priced after the intake questionnaire. PlexusDx Semaglutide Injection is $189/mo across five dose levels with no intro hook.

Is the MEDVi $299 monthly rate the standing rate?

No — MEDVi’s ongoing compounded semaglutide rate is $299/month. For comparison, PlexusDx Microdose GLP-1 Protocol at $129/mo flat totals $1,548/year — roughly $1,900 below MEDVi’s standard path on a 12-month basis with no intro pricing required.

Does MEDVi semaglutide cost more at higher doses?

MEDVi states publicly that compounded semaglutide injection refills are locked at $299/month regardless of dose, and patient reports generally corroborate that. PlexusDx Semaglutide Injection is $189/mo across all five dose levels — flat regardless of dose, and below MEDVi’s flat $299 refill.

How does MEDVi’s month-to-month pricing work?

Yes. MEDVi also offers prepaid multi-month plans, though the rate it publishes on an ongoing basis for semaglutide is $299/month. The tradeoff is an upfront multi-month commitment with stricter refund language. PlexusDx Semaglutide Injection at $189/mo totals $1,134 over six months with no commitment plan required.

Is MEDVi semaglutide injection or tablet cheaper?

MEDVi’s injection has a published ongoing rate of $299/month, while its dissolvable tablet is priced after the intake questionnaire — so a direct injection-versus-tablet comparison isn’t possible from public pricing alone. PlexusDx publishes both on canonical product pages: Semaglutide Injection at $189/mo and Semaglutide Oral $289/mo month-to-month, or from $249/mo on the 6-month plan, so you can compare both routes without checkout-time pricing surprises.

Is MEDVi semaglutide FDA-approved?

No. MEDVi’s core $299 offer is compounded semaglutide, prepared by licensed U.S. compounding pharmacies but not an FDA-approved finished drug product. The same applies to PlexusDx Semaglutide Injection and Semaglutide Oral — both are compounded. Only Wegovy, Ozempic, and Rybelsus are FDA-approved finished semaglutide products. The boxed warning for thyroid C-cell tumors applies to semaglutide based on rodent studies regardless of whether the formulation is branded or compounded.

Can I use HSA or FSA dollars for MEDVi or PlexusDx semaglutide?

Yes on both platforms. Prescription GLP-1 medications for medical weight management are generally HSA/FSA-qualified expenses under IRS rules when prescribed by a licensed clinician. Pre-tax dollars cut effective cost by roughly 22–35% depending on your tax bracket — bringing PlexusDx Semaglutide Injection at $189/mo to an effective $123–$147/mo and MEDVi’s $299 refill to an effective $194–$233/mo.

Related reading on PlexusDx

Related reading on PlexusDx: Semaglutide Cost, GLP-1 Cost, Cheapest GLP-1, Compounded Semaglutide vs Wegovy.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for MEDVi is based on its published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.